RE: What do we want to hear from CC later?30 Apr 2024 13:15
Cant understand why anyone is selling here.
Nothing is off the table
Chief business offer is very busy, multiple conversations ongoing.
Therapeutics - move to next chapter, pipeline of assets, precision can be implemented in many ways
Financing - answers coming soon
Diagnostics - maximize value - plan coming soon
Evolution of the board - Critical competencies required to go into next chapter
Presentation received very well received by scientists, oncologists who had ideas about choice of warheads.
Major pharma and biotech companies triggering new conversations.
Patient advocates asking about next steps for AVA6000 - this is key to enrolling patients for clinical trials